Cargando…
A controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso
BACKGROUND: In malaria-endemic countries, large proportions of infected individuals are asymptomatic, constituting a reservoir of parasites for infection of newly hatched mosquitoes. This study evaluated the impact of screening and treatment of asymptomatic carriers of Plasmodium falciparum. METHODS...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599538/ https://www.ncbi.nlm.nih.gov/pubmed/23442748 http://dx.doi.org/10.1186/1475-2875-12-79 |
_version_ | 1782262985901735936 |
---|---|
author | Tiono, Alfred B Ouédraogo, Alphonse Ogutu, Bernhards Diarra, Amidou Coulibaly, Sam Gansané, Adama Sirima, Sodiomon B O’Neil, Gregory Mukhopadhyay, Amitava Hamed, Kamal |
author_facet | Tiono, Alfred B Ouédraogo, Alphonse Ogutu, Bernhards Diarra, Amidou Coulibaly, Sam Gansané, Adama Sirima, Sodiomon B O’Neil, Gregory Mukhopadhyay, Amitava Hamed, Kamal |
author_sort | Tiono, Alfred B |
collection | PubMed |
description | BACKGROUND: In malaria-endemic countries, large proportions of infected individuals are asymptomatic, constituting a reservoir of parasites for infection of newly hatched mosquitoes. This study evaluated the impact of screening and treatment of asymptomatic carriers of Plasmodium falciparum. METHODS: Eighteen villages were randomized (1:1) to study arms and inhabitants participated in four community screening campaigns: three before the rainy season ~1 month apart, and the fourth after the rains at ~12 months. On day 1 of campaigns 1–3, asymptomatic carriers in the intervention arm were identified by rapid diagnostic test and treated with artemether-lumefantrine. Outcomes were symptomatic malaria with parasite density >5,000/μL per person-year in children < 5 years and change in haemoglobin between days 1 and 28 of campaign 1. RESULTS: At 12 months, the number of symptomatic malaria episodes with a parasite density >5,000/μL per person-year in children < 5 years was not significantly different between arms (1.69 vs 1.60, p = 0.3482). Mean haemoglobin change in asymptomatic carriers during campaign 1 was greater in the intervention vs control arm (+0.53 g/dL vs -0.21 g/dL, p < 0.0001). ANCOVA demonstrated that mean asymptomatic carriage at the cluster level was lower in the intervention vs control arm at day 1 of campaigns 2 (5.0% vs 34.9%, p < 0.0001) and 3 (3.5% vs 31.5%, p < 0.0001), but showed only a small difference at day 1 of campaign 4 (34.6% vs 37.6%, p = 0.2982). Mean gametocyte carriage was lower in the intervention vs control arm at day 1 of campaigns 2 and 3 (0.7% vs 5.4%, p < 0.0001; 0.5% vs 5.8%, p < 0.0001), but was similar at day 1 of campaign 4 (4.9% vs 5.1%, p = 0.7208). CONCLUSIONS: Systematic screening and treatment of asymptomatic carriers at the community level did not reduce clinical malaria incidence in the subsequent transmission season, indicating greater levels of parasite clearance are required to achieve a sustained impact in this setting. |
format | Online Article Text |
id | pubmed-3599538 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35995382013-03-17 A controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso Tiono, Alfred B Ouédraogo, Alphonse Ogutu, Bernhards Diarra, Amidou Coulibaly, Sam Gansané, Adama Sirima, Sodiomon B O’Neil, Gregory Mukhopadhyay, Amitava Hamed, Kamal Malar J Research BACKGROUND: In malaria-endemic countries, large proportions of infected individuals are asymptomatic, constituting a reservoir of parasites for infection of newly hatched mosquitoes. This study evaluated the impact of screening and treatment of asymptomatic carriers of Plasmodium falciparum. METHODS: Eighteen villages were randomized (1:1) to study arms and inhabitants participated in four community screening campaigns: three before the rainy season ~1 month apart, and the fourth after the rains at ~12 months. On day 1 of campaigns 1–3, asymptomatic carriers in the intervention arm were identified by rapid diagnostic test and treated with artemether-lumefantrine. Outcomes were symptomatic malaria with parasite density >5,000/μL per person-year in children < 5 years and change in haemoglobin between days 1 and 28 of campaign 1. RESULTS: At 12 months, the number of symptomatic malaria episodes with a parasite density >5,000/μL per person-year in children < 5 years was not significantly different between arms (1.69 vs 1.60, p = 0.3482). Mean haemoglobin change in asymptomatic carriers during campaign 1 was greater in the intervention vs control arm (+0.53 g/dL vs -0.21 g/dL, p < 0.0001). ANCOVA demonstrated that mean asymptomatic carriage at the cluster level was lower in the intervention vs control arm at day 1 of campaigns 2 (5.0% vs 34.9%, p < 0.0001) and 3 (3.5% vs 31.5%, p < 0.0001), but showed only a small difference at day 1 of campaign 4 (34.6% vs 37.6%, p = 0.2982). Mean gametocyte carriage was lower in the intervention vs control arm at day 1 of campaigns 2 and 3 (0.7% vs 5.4%, p < 0.0001; 0.5% vs 5.8%, p < 0.0001), but was similar at day 1 of campaign 4 (4.9% vs 5.1%, p = 0.7208). CONCLUSIONS: Systematic screening and treatment of asymptomatic carriers at the community level did not reduce clinical malaria incidence in the subsequent transmission season, indicating greater levels of parasite clearance are required to achieve a sustained impact in this setting. BioMed Central 2013-02-27 /pmc/articles/PMC3599538/ /pubmed/23442748 http://dx.doi.org/10.1186/1475-2875-12-79 Text en Copyright ©2013 Tiono et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Tiono, Alfred B Ouédraogo, Alphonse Ogutu, Bernhards Diarra, Amidou Coulibaly, Sam Gansané, Adama Sirima, Sodiomon B O’Neil, Gregory Mukhopadhyay, Amitava Hamed, Kamal A controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso |
title | A controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso |
title_full | A controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso |
title_fullStr | A controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso |
title_full_unstemmed | A controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso |
title_short | A controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso |
title_sort | controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of plasmodium falciparum in burkina faso |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599538/ https://www.ncbi.nlm.nih.gov/pubmed/23442748 http://dx.doi.org/10.1186/1475-2875-12-79 |
work_keys_str_mv | AT tionoalfredb acontrolledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso AT ouedraogoalphonse acontrolledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso AT ogutubernhards acontrolledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso AT diarraamidou acontrolledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso AT coulibalysam acontrolledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso AT gansaneadama acontrolledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso AT sirimasodiomonb acontrolledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso AT oneilgregory acontrolledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso AT mukhopadhyayamitava acontrolledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso AT hamedkamal acontrolledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso AT tionoalfredb controlledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso AT ouedraogoalphonse controlledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso AT ogutubernhards controlledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso AT diarraamidou controlledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso AT coulibalysam controlledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso AT gansaneadama controlledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso AT sirimasodiomonb controlledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso AT oneilgregory controlledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso AT mukhopadhyayamitava controlledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso AT hamedkamal controlledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso |